607
Participants
Start Date
January 31, 2012
Primary Completion Date
July 31, 2014
Study Completion Date
August 31, 2014
Lesinurad
Tablets, 200 mg once daily (qd)
Lesinurad
Tablets, 400 mg qd
Placebo
Tablets, Placebo qd
Allopurinol
Tablets, ≥ 300 mg QD (≥ 200 mg qd for subjects with moderate renal impairment)
Allopurinol
Tablets, ≥ 300 mg QD (≥ 200 mg qd for subjects with moderate renal impairment)
Allopurinol
Tablets, ≥ 300 mg QD (≥ 200 mg qd for subjects with moderate renal impairment)
New York
Syracuse
Endwell
Williamsville
Belle Vernon
Clairton
Wexford
Pittsburgh
Upper Saint Clair
Altoona
Duncansville
Sellersville
Jenkintown
Lansdale
Manassas
Midlothian
Richmond
Richmond
Chesapeake
Suffolk
Virginia Beach
Morgantown
Winston-Salem
Greensboro
Raleigh
Raleigh
Shelby
Wilmington
Tabor City
Columbia
Spartanburg
Mt. Pleasant
Myrtle Beach
Rock Hill
Conyers
Marietta
Johns Creek
Newnan
Atlanta
Atlanta
Augusta
Daytona Beach
Port Orange
Ormond Beach
Gainesville
Vero Beach
Pembroke Pines
Pembroke Pines
Miami
Miami
Miami
Miami
Miami
Tampa
Clearwater
Naples
East Bradenton
Ocala
Brooksville
Pinson
Birmingham
Birmingham
Birmingham
Birmingham
Athens
Gulf Shores
Mobile
Mobile
Brentwood
Knoxville
Memphis
Jackson
Jackson
Elizabethtown
Paducah
Columbus
Perrysburg
Willoughby Hills
Dayton
Franklin
La Porte
Evansville
Southfield
Ann Arbor
Kalamazoo
Traverse City
Cedar Rapids
Milwaukee
Monroe
Missoula
Gurnee
Chicago
Florissant
Hazelwood
Washington
St Louis
St Louis
Kansas City
Jefferson City
Shawnee
Metairie
Eunice
Monroe
Natchitoches
Little Rock
Little Rock
Little Rock
Oklahoma City
Tulsa
Plabo
Plano
Dallas
Fort Worth
Waco
San Angelo
Houston
Houston
Nassau Bay
Houston
Houston
Kingwood
Sealy
San Antonio
San Antonio
San Antonio
Corpus Christi
Austin
El Paso
Englewood
Denver
Colorado Springs
Colorado Springs
Idaho Falls
Meridian
Meridian
Bountiful
West Jordan
Salt Lake City
Phoenix
Glendale
Peoria
Goodyear
Tucson
Tuscon
Albuquerque
Las Vegas
Las Vegas
Inglewood
Glendale
Covina
Huntington Beach
Orange
Santa Maria
Lancaster
San Leandro
Lincoln
Sacramento
Honolulu
Ashland
Port Orchard
Spokane
Spokane
Milford
New London
Worcester
Lead Sponsor
Ardea Biosciences, Inc.
INDUSTRY